• What are Semaglutide and Tirzepatide?

  Semaglutide is a prescription medication used to treat type 2 diabetes and obesity. It is a glucagon-like peptide-1 (GLP-1) receptor agonist, which means it mimics the action of the naturally occurring hormone GLP-1 in the body. Tirzepatide mimics the GIP pathway in addition to the GLP-1 pathway. These medications help regulate blood sugar levels. They also slow down the rate at which food moves through the stomach, which can reduce appetite and promote weight loss. They are typically administFew readers

• How long should I stay on these medications?

  Semaglutide and Tirzepatide are currently approved by the FDA for long-term use in the treatment of obesity. Patients who stop the medication gain back on average two thirds of the weight they had lost. It is recommended that patients remain on a maintenance dose to curb cravings and maintain the new weight.Few readers

• What side effects are commonly experienced?

  These medications can cause side effects in some patients. Some of the commonly reported side effects include: Nausea Diarrhea Vomiting Constipation Abdominal pain Loss of appetite Headache Fatigue Dizziness These side effects are usually mild to moderate in intensity and tend to improve over time as the body adjusts to the medication. However, if these side effects persist or become severe, patients should contact their healthcare provider for further evaluation and guidanceFew readers

• Who should these medications be prescribed for?

  These medications are used to treat type 2 diabetes and obesity. Type 2 diabetes: They are used as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes. They may be used alone or in combination with other diabetes medications. Obesity: They are used as an adjunct to a reduced-calorie diet and increased physical activity to help promote weight loss in adults with a body mass index (BMI) of 30 or higher, or in adults with a BMI of 27 or higher who have at lFew readers

• What weight loss results can I expect?

  Up to 20% with Semaglutide and up to 27% with TirzepatideFew readers